tiprankstipranks
Advertisement
Advertisement

CareRx Posts First Full-Year Profit, Boosts Margins and Launches Dividend in 2025

Story Highlights
  • CareRx grew revenue, beds serviced and margins in 2025, delivering its first full year of positive net income.
  • The company reduced net debt, began paying dividends and repurchased shares, signaling confidence in scalable growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CareRx Posts First Full-Year Profit, Boosts Margins and Launches Dividend in 2025

Claim 55% Off TipRanks

An announcement from CareRx ( (TSE:CRRX) ) is now available.

CareRx reported 2025 revenue of $370.2 million, modestly higher than a year earlier, with average beds serviced rising to 92,250 in the fourth quarter and Adjusted EBITDA improving to $32.9 million and margins to 8.9%. The company posted its first full year of positive net income at $26.1 million, strengthened its balance sheet by reducing net debt, initiated a quarterly dividend and share buybacks, and said operational efficiencies and platform expansion position it to benefit from growth in seniors housing.

Fourth-quarter revenue climbed to $96.1 million, while Adjusted EBITDA rose to $8.8 million and cash from operations reached $9.6 million, reflecting contributions from newly onboarded beds and cost-saving initiatives. CareRx’s move to return capital via dividends and its renewed share repurchase program underscore confidence in its cash generation and signal a more shareholder-friendly posture as it targets further scalable growth with its operator partners.

The most recent analyst rating on (TSE:CRRX) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on CareRx stock, see the TSE:CRRX Stock Forecast page.

Spark’s Take on TSE:CRRX Stock

According to Spark, TipRanks’ AI Analyst, TSE:CRRX is a Neutral.

CareRx’s overall stock score is driven by a strong earnings call performance, highlighting revenue and EBITDA growth, positive net income, and reduced debt. However, financial performance is hindered by negative net margins and high reliance on debt. Technical indicators suggest a neutral trend, while the valuation appears stretched with a high P/E ratio. The dividend initiation provides a positive signal of financial confidence.

To see Spark’s full report on TSE:CRRX stock, click here.

More about CareRx

CareRx Corporation is a Canadian pharmacy services provider focused on seniors living and other congregate care communities across the country. The company serves tens of thousands of beds, partnering with home operators to deliver medication management and related pharmacy solutions in long-term care and retirement settings.

Average Trading Volume: 72,374

Technical Sentiment Signal: Buy

Current Market Cap: C$240.3M

Learn more about CRRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1